tiprankstipranks
Trending News
More News >
ABVC BioPharma, Inc. (ABVC)
NASDAQ:ABVC
US Market

ABVC BioPharma (ABVC) Financial Statements

Compare
102 Followers

ABVC BioPharma Financial Overview

ABVC BioPharma's market cap is currently $23.15M. The company's EPS TTM is $-0.144; its P/E ratio is ―; ABVC BioPharma is scheduled to report earnings on March 28, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 508.83K$ 152.43K$ 969.78K$ 355.80K$ 483.05K
Gross Profit$ 508.06K$ -149.61K$ 683.37K$ 350.71K$ 464.33K
Operating Income$ -4.71M$ -8.22M$ -15.11M$ -11.35M$ -8.51M
EBITDA$ -4.34M$ -8.13M$ -15.20M$ -10.97M$ -10.37M
Net Income$ -4.90M$ -10.52M$ -16.31M$ -12.04M$ -10.59M
Balance Sheet
Cash & Short-Term Investments$ 313.12K$ 139.47K$ 161.06K$ 5.94M$ 4.27M
Total Assets$ 7.54M$ 14.49M$ 9.86M$ 13.70M$ 11.61M
Total Debt$ 2.43M$ 2.28M$ 3.05M$ 3.11M$ 6.48M
Net Debt$ 2.18M$ 2.22M$ 2.97M$ -2.72M$ 2.21M
Total Liabilities$ 6.82M$ 6.36M$ 6.24M$ 4.83M$ 8.94M
Stockholders' Equity$ 1.23M$ 8.39M$ 3.10M$ 8.84M$ 3.44M
Cash Flow
Free Cash Flow$ -1.81M$ -4.26M$ -7.52M$ -7.62M$ -4.56M
Operating Cash Flow$ -1.81M$ -4.24M$ -7.40M$ -7.60M$ -4.56M
Investing Cash Flow$ 0.00$ -360.19K$ -1.72M$ -805.97K$ -225.43K
Financing Cash Flow$ 1.98M$ 3.92M$ 4.01M$ 10.00M$ 9.57M
Currency in USD

ABVC BioPharma Earnings and Revenue History

ABVC BioPharma Debt to Assets

ABVC BioPharma Cash Flow

ABVC BioPharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis